ABA 0.00% $5.15 abano healthcare group limited

Ann: GENERAL: ABA: Unsolicited Indicative Proposa

  1. lightbulb Created with Sketch. 2
    • Release Date: 16/09/13 11:44
    • Summary: GENERAL: ABA: Unsolicited Indicative Proposal Update
    • Price Sensitive: No
    • Download Document  4.52KB
    					
    
    ABA
    16/09/2013 09:44
    GENERAL
    
    REL: 0944 HRS Abano Healthcare Group Limited
    
    GENERAL: ABA: Unsolicited Indicative Proposal Update
    
    Abano Healthcare Group Limited (NZX:ABA) advises that on Friday afternoon (13
    September 2013), Australian owned private equity firm Archer Capital, with
    the support of Abano director Peter Hutson, approached Abano again to
    reactivate its previous unsolicited indicative proposal.
    
    Although the proposal has not materially changed, the Abano Board (excluding
    Mr Hutson) has, over the weekend, again carefully considered Archer's
    proposal, which now involves:
    
    - A downwards adjustment of the indicative price range to $6.97 to $7.14 per
    share, to take account of the recent 13.7 cent dividend and capital raisings
    (placement and Share Purchase Plan), with the pricing subject to due
    diligence. Archer prefers a scheme of arrangement structure, given its lower
    voting threshold and other perceived advantages for Archer.
    
    - Due diligence information requirements, principally on Abano's dental
    business, which may or may not result in the indicative price changing.
    
    - Audiology business to be divested post-acquisition, for a nominal sum, to
    interests associated with Peter Hutson.
    
    - Mr Hutson's interests are to continue, and potentially increase, their
    investment in the company including its dental and other businesses. A
    continued (re) investment opportunity is understood to have been offered to
    an associate of Mr Hutson, Mr James Reeves, whose interests own approximately
    5% of Abano. Archer has advised that no such option has been or is proposed
    to be offered to any other shareholder.
    
    The non-conflicted members of the Board remain of the view that progressing a
    possible sale of the company on these terms is not in the interests of the
    company or all its shareholders.
    
    - Archer's indicated price range falls well below the level the Board
    considers reflects fair value for a 100% control transaction, particularly
    having regard to prices recently paid for consolidated dental businesses in
    Australia and the various growth stages of each of Abano's existing
    businesses.
    
    - Archer has said it has a long-standing and well researched interest in the
    dental sector and has a stated intention to invest into the dental sector.
    Archer is a well-resourced potential competitor and the information it has
    requested is confidential and competitively sensitive.
    
    - Archer's intended strategy, as advised, is to inject capital, in a private
    setting, and in conjunction with the Hutson interests, into an apparently
    more aggressive dental aggregation strategy. The Board notes that any
    limitation on the pace of the current dental practice aggregation does not
    flow from any lack of capital but from the realities of the time and
    management effort required to implement a successful and long term,
    sustainable integration strategy.
    
    - The independent directors of the Board are confident in the company, its
    management, strategic plan and its own assessment of long term value
    creation. The Board does not believe Archer's involvement would yield any
    benefit other than a potential short term liquidity option for shareholders.
    It notes Archer is not restricted from pursuing any initiatives in accordance
    with the takeover mechanisms provided under New Zealand law should it wish to
    do so.
    
    The non-conflicted members of the Board have therefore again rejected the
    unsolicited approach from Archer Capital and Abano director Peter Hutson. As
    a consequence of Mr Hutson's  conflicts of interest, the non-conflicted
    directors have excluded him from their deliberations. Abano is unaware as to
    whether Archer proposes to continue with its attempts to engage with the
    company or to withdraw, and accordingly is not in a position to assess what,
    if any, prospects there are of an offer being forthcoming.
    
    The Board notes that the current Share Purchase Plan (SPP), which opened on
    the 13th of September 2013, is the second stage of the equity capital raising
    programme announced to the market on 30 July 2013. After several months of
    planning, this capital raising programme was in the final stages of being
    implemented when the first approach was received from Archer and Peter
    Hutson.
    
    Shareholders should have received their mailed Share Purchase Plan documents
    and are reminded that application forms and payment must be received by the
    share registrar, Computershare Investor Services Limited, by 5.00pm on 1
    October 2013 (unless the closing date is extended in accordance with the
    Listing Rules).
    
    Trevor Janes
    Chairman
    
    ENDS
    End CA:00241133 For:ABA    Type:GENERAL    Time:2013-09-16 09:44:42
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.